Consensus statement on the need for innovation, transition and implementation of developmental neurotoxicity (DNT) testing for regulatory purposes

E. Fritsche, P.J. Lein, M. Leist, W.R. Mundy, M. Paparella, A.H. Piersma, M. Sachana, G. Schmuck, R. Solecki, A. Terron, F. Monnet-Tschudi, P. Grandjean, M.F. Wilks, H. Witters, M.-G. Zurich, A. Bal-Price, K.M. Crofton, M. Aschner, A. Goldberg, T. HeinonenE.V.S. Hessel, H.T. Hogberg, S.H. Bennekou

    Research output: Contribution to journalComment/debateScientific

    47 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)3-6
    JournalToxicology and Applied Pharmacology
    Volume354
    DOIs
    Publication statusPublished - 2018
    Publication typeB1 Article in a scientific magazine

    Keywords

    • Developmental neurotoxicity
    • In vitro testing
    • Regulatory purposes

    Cite this